Intervention

PD-1 inhibitor

ClinicalTrials.gov intervention label

Clinical trials11
Recruiting2
Common conditions25
Lead sponsors shown8

Clinical trials

11 shown
PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLCNCT06977074 · 2025-05-10
RECRUITING
An Observational Clinical Study of Stereotactic Radiotherapy for Advanced Non-Small Cell Lung Cancer With Stable Disease After PD-1 Inhibitor TreatmentNCT05486650 · 2022-08-01
RECRUITING
Local Ablation Plus Systemic Therapy for Metachronous Liver and/or Lung Oligometastases From Nasopharyngeal CarcinomaNCT07824856 · 2026-10-01
NOT_YET_RECRUITING
Observational Study on the Sensitivity of Neoadjuvant Immunotherapy in Early Triple-Negative Breast CancerNCT06448169 · 2024-05-30
UNKNOWN
PD1 and PARP for Maintenance Therapy in NSLLCNCT05392686 · 2022-06-20
UNKNOWN
CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLCNCT04681131 · 2021-03-17
COMPLETED
Neoadjuvant Immunotherapy With Chemotherapy for Stage I-IIIB Non-Small Cell Lung Cancer PatientsNCT04941417 · 2020-11-24
UNKNOWN
PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort StudyNCT04115410 · 2020-07-01
UNKNOWN
Assessing Safety and Efficacy of Sintilimab and Metformin Combination Therapy in SCLCNCT03994744 · 2019-08-20
UNKNOWN
Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine CancerNCT04239443 · 2019-01-30
UNKNOWN
CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2)NCT03504488 · 2018-06-27
COMPLETED

Common conditions

Non Small Cell Lung Cancer2Triple Negative Breast Cancer2Ablation Techniques1Advanced Non Small Cell Lung Cancer1Carcinoma, Non-Small-Cell Lung1Head and Neck Cancer1Immune-Related Adverse Events1Liver Metastases1Lung Cancer1Lung Metastases1Melanoma1Nasopharyngeal Carcinoma1Neoadjuvant Immunotherapy1Neoplasm Metastasis1Non-small Cell Lung Cancer1Non-small Cell Lung Cancer (NSCLC)1Non-Small-Cell Lung Cancer1Oligometastatic Disease1Sensitivity1Small Cell Lung Cancer Extensive Stage1Small Cell Lung Cancer Recurrent1Small Cell Lung Carcinoma1Small-cell Lung Cancer1Soft Tissue Sarcoma1Uterine Cancer1

Trial status mix

UNKNOWN6
COMPLETED2
RECRUITING2
NOT_YET_RECRUITING1

Phase mix

PHASE28
PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.